Neurocrine Biosciences, Inc <NBIX.O>: BofA Global Research raises price objective to $214 from $199
NBIX•Related News
BUZZ-U.S. stocks on the move-Amazon, Monolithic Power Systems, Eaton Corp
SPY•
Nasdaq 100 leads US futures higher as Amazon surge offsets Apple decline
SPY•
RBC Bearings Q1 Adjusted EPS USD 3.88 Vs. IBES Estimate USD 3.43
RBC•
Rtx's Pratt & Whitney Awarded $1.3 Billion F135 Sustainment Contract
RTX•
Alnylam Pharmaceuticals Inc <ALNY.O>: Raymond James Cuts Target Price to $420 From $468
ALNY•